U.S. Markets close in 3 hrs 33 mins

Sanofi (SAN.PA)


Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
84.54-2.16 (-2.49%)
At close: 5:35PM CEST
People also watch
FP.PABN.PACS.PAOR.PAAI.PA
Full screen
Previous Close86.70
Open86.80
Bid71.12 x 1000
Ask71.74 x 44000
Day's Range84.31 - 86.81
52 Week Range66.72 - 92.97
Volume2,940,094
Avg. Volume2,431,396
Market Cap103.35B
Beta0.73
PE Ratio (TTM)11.69
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield3.30 (3.35%)
Ex-Dividend Date2017-05-16
1y Target EstN/A
  • The Crazy Math Behind Drug Prices
    Bloomberg27 minutes ago

    The Crazy Math Behind Drug Prices

    Intermediaries that negotiate to lower prices may cause them to increase, too.

  • Robust 1H for Pharma/Biotech Sector, 3 Big Stocks to Buy
    Zacks2 hours ago

    Robust 1H for Pharma/Biotech Sector, 3 Big Stocks to Buy

    The pharma and biotech industry has been blessed with good health in the first half of the year.

  • Barrons.com2 days ago

    Regeneron: The More the Merrier?

    Last week we noted that when a stock has a big rally, analysts are forced to either cut their rating or raise their target price. Today, Leerink's Geoffrey Porges and Bradley Canino raise their Regeneron target to $573 from $483: After lots of news in the last week, and a major shift in value, and expectations, we are updating our Regeneron model to incorporate higher expected sales of Dupixent (including adult atopic dermatitis, pediatric atopic dermatitis, high eosinophil and non-eosinophilic asthma), lower expected sales of Eylea (accounting for some erosion by RTH258 starting in 2019), and including for the first time revenue from REGN2810, which is the company’s joint (with Sanofi (SNY)) PD-1 antibody.